Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Life Sciences - February, 2004
31 articles
- Federal Circuit Rules For Pfizer In Suit Over Norvasc Patent
- Canada Antitrust Watchdog Rejects Probe Over Drug-Patent Evergreening Tactics
- Study Finds Limited Impact Of New FDA Rule On 30-Month Stays In Drug Patent Challenges
- Malaysia Issues World's First Compulsory License
- Pfizer Sues Dr. Reddy's Over ANDA For Norvasc Generic
- Guidant, J&J's Cordis Settle Patent Dispute Over Drug-Coated Stents
- Indiana University Sues Merck Over Patents For Papilloma Vaccine
- Insurers File Antitrust Suit Vs. Purdue Over Oxycontin Patents
- Quidel Strikes Back With Patent Lawsuits Against Rivals
- Boston Scientific , Guidant Settle Patent Suits Over Drug-Coated Stents
- Judge Dismisses Patent Suit Against Amgen
- WHO Sets Up Panel To Review IPR Impact On Drugs
- India To Form Panel To Review Data Protection
- Pfizer Faces Setbacks In Patent Battle Over Viagra
- Drug Companies Seek Trademarks At Early Stage, Survey Finds
- FDA Reviews Process For Approving Biotech Generics
- U.S. To Review Chiron's Hepatitis C Patent Deal
- Federal Circuit Upholds Ruling Invalidating University of Rochester's Patent
- FTC Closes Antitrust Probe Of Allergan's Acular Drug
- Energizer Sues Gillette Over Razor Patents
- Canada Parliament Mulls Government's Patent Law Amendments
- PharmaStem Sues Five Rivals Over Umbilical Cord Blood Banking
- Inventors Win $5M Settlement In Dispute Over Dental Implant Technology
- FDA To Appeal Ruling On 180-Day Shared Exclusivity
- Glaxo Sues Israeli Drug Maker For Trademark Infringement
- FDA To Review Approval Of Norvasc Generic As 505 (b) (2) Gateway Is Tested In Court
- Glaxo Pays $175 Million To Settle Antitrust Suit Over Relafen Patent
- AstraZeneca Sues Andrx Over Tropol-XL Patent
- Guidant Sues St. Jude Over Pacemaker Defibrillators
- Federal Circuit Rules For Shwarz Pharma In Suit Over Univasc Patent
- Boston Scientific, Johnson & Johnson To Square Off In Court In June 2005